viernes, 29 de marzo de 2019

How can advances in computerized decision support systems best be used to improve antimicrobial stewardship? - On Medicine

How can advances in computerized decision support systems best be used to improve antimicrobial stewardship? - On Medicine

Stephen Hughes, Katie Heard & Luke Moore

Stephen is a Consultant antimicrobial pharmacist with an interest in optimising the pathway to impact for enabling strategies in antimicrobial stewardship. He also has a keen interest in the pharmacokinetics and pharmacodynamics of antimicrobials for difficult to treat infections, and for enhancing care for those who require prolonged courses. 

Katie is a specialist antimicrobial pharmacist working in London with interests in dose optimisation, outpatient parenteral antimicrobial therapy, and using technology to aid stewardship. Her current work focuses on using technology to enable quality and efficiency improvements within antimicrobial stewardship. She is an advocate of a 'handshake stewardship' approach, over a restrictive process to better engage and educate clinicians.

Luke is an Infectious Diseases Physician and Clinical Microbiologist with special interests in critical care infections, antimicrobial resistance, and decision support systems. He works clinically for secondary and tertiary care patients with infections in London, whilst my current research focuses on the epidemiology of antimicrobial resistance and outbreak detection, and on intelligent systems to aid antimicrobial stewardship.


How can advances in computerized decision support systems best be used to improve antimicrobial stewardship?

Antimicrobial stewardship programs aim to ensure the responsible use of antibiotics, balancing the needs of the patient against the impact of broad spectrum antibiotic use leading to antimicrobial resistance. Recently published research in Antimicrobial Resistance & Infection Control tests the effectiveness of computerized decision support systems in improving antimicrobial stewardship programs. Here the authors discuss their results and why improving stewardship is so vital.
We all probably agree that a successful antimicrobial stewardship program (AMS) should aim to improve patient treatment outcomes, improve patient safety, and reduce the impact of antimicrobial resistance (AMR) in patients and the wider society. Yet how to implement a successful, resilient, AMS program is less well understood.

No hay comentarios:

Publicar un comentario